HCPCS code J0737 — Inj, clindamycin (baxter).
Status: Active.
Effective Jan 1, 2024.
Source: CMS HCPCS Level II.
J0737
ActiveInj, clindamycin (baxter)
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Jan 1, 2024
Code type:
alphanumeric
OPPS Status:
N
— Items / services packaged into APC rates
MUE — Medically Unlikely Edits
Maximum units of J0737 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| Outpatient Hospital | 9 |
| Practitioner Services | 9 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 00338-9545-24 | Clindamycin Phosphate |
| 00338-9549-24 | Clindamycin Phosphate |
| 00338-9553-24 | Clindamycin Phosphate |
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2024-Q1Inj, clindamycin (baxter)